Persistently elevated β-human chorionic gonadotropin level after vacuum-assisted uterine aspiration: a case report

Table 1 HCG trend through the clinical course

Date of collection	Laboratory test	Value	Relevant clinical history
7 April 2020	HCG quantitative	1800 mU/mL	Presentation for incomplete abortion
24 April 2020	HCG quantitative	12.5 mU/mL	Post-abortion surveillance
2 September 2020	HCG quantitative	23.6 mU/mL	Presentation for non-gynecologic, orthopedic surgery
9 September 2020	HCG quantitative	20.8 mU/mL	Repeat testing for verification of HCG result
11 September 2020	HCG quantitative	24.5 mU/mL	Evaluation of hypothalamic-pituitary axis
	FSH	10.7 mU/mL
	LH	5.0 mU/mL
	HCG qualitative	Positive
19 October 2020	HCG quantitative	22.6 mU/mL	Evaluation of HCG level after hysteroscopy
22 October 2020	HCG quantitative	28.7 mU/mL	Pre-methotrexate therapy
22 October 2020	HCG quantitative	27.0 mU/mL	Post-methotrexate therapy
4 November 2020	HCG quantitative	27 mU/mL	Prior to urologic resection of bladder tumor
9 December 2020	HCG quantitative	< 1 mU/mL	Post-urologic resection of bladder tumor

Human chorionic gonadotropin (HCG) reference range < 5.0 mU/mL. Follicle-stimulating hormone (FSH) reference range based on phase—follicular, 2–11 mU/mL; mid-cycle, 10–30 mU/mL; luteal, 1–9 mU/mL; postmenopausal, 20–100 mU/mL. Luteinizing hormone (LH) reference range based on phase—follicular, 1–12 mU/mL; mid-cycle, 20–90 mU/mL; luteal, 1–10 mU/mL; postmenopausal, > 20 mU/mL

ISSN: 1752-1947